Page last updated: 2024-09-02

cinnabarinic acid and purpurin

cinnabarinic acid has been researched along with purpurin in 1 studies

Compound Research Comparison

Studies
(cinnabarinic acid)
Trials
(cinnabarinic acid)
Recent Studies (post-2010)
(cinnabarinic acid)
Studies
(purpurin)
Trials
(purpurin)
Recent Studies (post-2010) (purpurin)
3601919012

Protein Interaction Comparison

ProteinTaxonomycinnabarinic acid (IC50)purpurin (IC50)
Female germline-specific tumor suppressor gld-1Caenorhabditis elegans6.688
Cytochrome P450 1A1Homo sapiens (human)5.5
Amine oxidase [flavin-containing] AHomo sapiens (human)3.8725
Cytochrome P450 1B1Homo sapiens (human)2.2
Thiosulfate sulfurtransferaseHomo sapiens (human)2.3
60 kDa chaperonin Escherichia coli4
10 kDa chaperonin Escherichia coli4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lefin, R; Petzer, A; Petzer, JP1

Other Studies

1 other study(ies) available for cinnabarinic acid and purpurin

ArticleYear
Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
    Bioorganic & medicinal chemistry, 2022, 01-15, Volume: 54

    Topics: Anthraquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenothiazines; Structure-Activity Relationship

2022